55MEDIUM

SOM

SOMNOMED FPO [SOM]
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Healthcare · ASX Small Cap
$0.6500 +0.0%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical55
Catalyst53
Sentiment50
Fundamental86
Momentum57
Risk Gate50
Get alerts when SOM's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track SOM — Free

Active Signals

Bullish Signals

  • Beating the Small Ords index — relative strength of 1.10, so it's outpacing the pack
  • Volatility is contracting — like a spring being compressed, breakouts often follow
  • Cash positive / operating cashflow positive
  • Low P/S ratio (1.2x)
  • Moderate revenue growth (+13%)
  • EPS estimates revised upward (+10pts)
  • CANSLIM I: Institutional ownership (58%)
  • Sentiment is mixed — no strong consensus either way
  • RBA hiking (-3pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Negative profit margins (-2%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • The bigger volume days are the down days — volume-weighted momentum is negative (-0.85%/day)
  • Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about SOM
"What's driving SOM's score?" "How does SOM compare to peers?" "Key risks for SOM?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Notification regarding unquoted securities - SOM
NONE Application for quotation of securities - SOM
NONE Application for quotation of securities - SOM
LOW Investor presentation
Announcement tone +3pts

Recent ASX Announcements

2026-03-20 Notification regarding unquoted securities - SOM
2026-03-18 Application for quotation of securities - SOM
2026-03-09 Application for quotation of securities - SOM
2026-03-09 Notification of cessation of securities - SOM
2026-02-26 Investor presentation PRICE SENSITIVE

Key Metrics

$142.4M
Market Cap
57K
Avg Volume
1.2x
Vol Ratio
$0.37 — $0.94
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-5.2%
ROE
-2.2%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 52%
LLeader vs LaggardlaggardRS: -4
IInstitutional SponsorshippassInst: 58%
MMarket DirectionneutralNeutral

Sector: Healthcare

Ranked #8 of 117 · Sector avg: 46

View all Healthcare signals →
Related Tickers
ATX 59PNV 56IMM 55EYE 55AHC 55
Compare:SOM vs ATXSOM vs PNVSOM vs IMM
Scout Pro — Deeper Analysis for SOM
Try Pro free for 30 days
Share this analysis

Track SOM and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required